AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ)
$12.54 -0.26 (-2.0313%)
Analysed AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) News Sources
AMRX: 3 Growth Drivers Behind Amneal's 2026 Outlook
10-04-2026
yahoo.com
Is AMRX Stock Undervalued? Sales Multiple, Target, Upside
10-04-2026
yahoo.com
Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing
10-04-2026
yahoo.com
A Look At Amneal Pharmaceuticals (AMRX) Valuation After Launching Its New Glaucoma Generic
09-04-2026
yahoo.com
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
09-04-2026
yahoo.com
3 of Wall Street’s Favorite Stocks We Steer Clear Of
08-04-2026
yahoo.com
Amneal to Report First Quarter 2026 Results on May 1, 2026
07-04-2026
yahoo.com
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month
07-04-2026
yahoo.com
3 Small-Cap Stocks Walking a Fine Line
30-03-2026
yahoo.com
Is Amneal Pharmaceuticals (AMRX) Pricing Reflect Its DCF Gap And Recent Share Slide
14-03-2026
yahoo.com
What is the current price of AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ)?
The current price of AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) is $12.54.
AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) since the previous trading day is $-0.26.
AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) since the previous trading day is -2.0313%.
What is the most recent average sentiment score for AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ)?
The most recent average sentiment score for AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ)?
The most recent sentiment for AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) is .
SEC-8K** Filing Available For AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.